Hyderabad Telangana, India

Bala Ankireddy Konda

This inventor holds 1 USPTO granted patent. Top assignee: Natco Pharma Limited. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bala Ankireddy Konda. Retrieved from https://idiyas.com/inventor/bala-ankireddy-konda

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Journey of Bala Ankireddy Konda

Introduction

Bala Ankireddy Konda is a prominent inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of processes for drug preparation. His work is characterized by a focus on efficiency and purity, which is crucial in the pharmaceutical industry.

Latest Patents

Bala Ankireddy Konda holds a patent for a process for the preparation of Ibrutinib. This invention relates to an improved method that ensures high purity and high yields. The process is not only cost-effective but also feasible for large-scale production. Importantly, it avoids the use of mitsunobu reagent conditions, which can complicate the synthesis. Additionally, the invention includes methods for preparing Crystalline form A and Crystalline form C of Ibrutinib.

Career Highlights

Bala Ankireddy Konda is associated with Natco Pharma Limited, a well-known pharmaceutical company. His role at Natco Pharma has allowed him to apply his innovative ideas in a practical setting, contributing to the company's reputation for quality and efficiency in drug manufacturing.

Collaborations

Some of his notable coworkers include Pulla Reddy Muddasani and Shankar Reddy Budideti. Their collaboration has likely fostered an environment of innovation and shared expertise within the company.

Conclusion

Bala Ankireddy Konda's contributions to the pharmaceutical industry through his patent for Ibrutinib preparation exemplify the importance of innovation in drug development. His work not only enhances production efficiency but also ensures the quality of pharmaceutical products.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…